⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL676463 | 0.72 | — | — | |
| SCHEMBL8052611 | 0.67 | — | — | |
| SCHEMBL12226 | 0.67 | — | — | |
| SCHEMBL1407388 | 0.67 | — | — | |
| SCHEMBL1407387 | 0.67 | — | — | |
| Ethoxycarbonyl Group SCHEMBL27767802 | 0.65 | — | — | |
| SCHEMBL209 | 0.64 | — | — | |
| SCHEMBL6109145 | 0.64 | CASP1 (0.30) | — | |
| SCHEMBL2957555 | 0.64 | — | — | |
| SCHEMBL27303540 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113454212-A | Modified terminal deoxynucleotidyl transferase (TdT) | 纽克莱生物科技有限公司 | 2021-09-28 | — | — | CN | claimed |
| CN-110603038-A | Rapamycin analogs | 塔姆山治疗公司 | 2019-12-20 | — | — | CN | claimed |
| CN-101044138-A | Indazole compounds and their use as herbicides | PFIZER (US) | 2007-09-26 | — | — | CN | claimed |
| CN-1149296-A | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 1997-05-07 | — | — | CN | claimed |
| CN-113840929-B | Oligonucleotide synthesis method | 核蛋白有限公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024052692-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052690-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| EP-4301752-A1 | BENZO[C][2,6]NAPHTHYRIDINE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2024-01-10 | — | — | EP | disclosed |
| US-11866436-B2 | Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-01-09 | — | — | US | disclosed |
| CN-117295736-A | Benzo [ C ] [2,6] naphthyridine derivatives, compositions thereof and therapeutic uses thereof | 剑桥实业有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-1059905-C | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 2000-12-27 | — | — | CN | disclosed |
| US-6143743-A | TREATMENT OF NERVOUS SYSTEM DISORDERS | DUPONT PHARMACEUTICALS COMPANY (US) | 2000-11-07 | — | — | US | disclosed |
| EP-0994877-A1 | IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | Du Pont Pharmaceuticals Company (US) | 2000-04-26 | — | — | EP | disclosed |
| WO-1999001454-A1 | IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-01-14 | — | — | WO | disclosed |
| CN-1202887-A | Tetrahydroquinolines as NMDA antagonists | GLAXO WELLCOME SPA (IT) | 1998-12-23 | — | — | CN | disclosed |
| CN-1149296-A | Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PROD (US) | 1997-05-07 | — | — | CN | disclosed |
| CN-1095379-A | Condensed heterocyclic derivates and weedicide | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1994-11-23 | — | — | CN | disclosed |
| US-5084567-A | Electroconductive charge transfer compounds | CIBA-GEIGY CORPORATION (US) | 1992-01-28 | — | — | US | disclosed |